Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11534494 Formulation and method of synthesis

Patent 11534494 was granted and assigned to GE Healthcare on December, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

GE Healthcare

Current Assignee

GE Healthcare

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

115344940

Patent Inventor Names

Kristine Romoren0

Torild Wickstrom0

Thanushan Rajanayagam0

Olav Ryan0

Knut Richard Dyrstad0

Date of Patent

December 27, 2022

Patent Application Number

169971880

Date Filed

August 19, 2020

Patent Citations

‌

US Patent 10010632 Precursor compound of radioactive halogen-labeled organic compound

Patent Primary Examiner

CPC Code

The present invention provides a novel method for the preparation of

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11534494 Formulation and method of synthesis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API